Literature DB >> 17249273

Early gastric cancer: diagnosis and less invasive treatments.

T Sano1, A Hollowood.   

Abstract

The prognosis of early gastric cancer (EGC) is excellent worldwide. Incidence of EGC shows considerable geographic variation, and in high prevalence areas where diagnostic skills are adept, EGCs are not frequently overlooked. In these countries, less invasive, function-preserving treatments such as endoscopic mucosal resection and pylorus-preserving gastrectomy have become standard options. The criteria to apply conservative treatments are being expanded along with the technological improvement. Though its natural history is relatively long, EGC could be a fatal disease and should be carefully treated. Lymph node metastasis is the most important prognostic factor that should be considered in treatment selection and follow-up planning of EGC.

Entities:  

Mesh:

Year:  2006        PMID: 17249273     DOI: 10.1177/145749690609500407

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  20 in total

1.  Comprehension of readmission after laparoscopy assisted distal gastrectomy: what are the causes?

Authors:  Min-Chan Kim; Ki-Han Kim; Yoo-Min Kim; Ghap-Joong Jung
Journal:  Ann Surg Treat Res       Date:  2014-04-24       Impact factor: 1.859

2.  A meta-analysis of randomized controlled trials that compared laparoscopy-assisted and open distal gastrectomy for early gastric cancer.

Authors:  Hiroshi Ohtani; Yutaka Tamamori; Kozo Noguchi; Takashi Azuma; Shunsuke Fujimoto; Hiroko Oba; Tetsuya Aoki; Mieko Minami; Kosei Hirakawa
Journal:  J Gastrointest Surg       Date:  2010-03-31       Impact factor: 3.452

3.  Solitary lymph node metastasis in gastric cancer.

Authors:  Chen Li; Sungsoo Kim; Ji Fu Lai; Sung Jin Oh; Woo Jin Hyung; Won Hyuk Choi; Seung Ho Choi; Sung Hoon Noh
Journal:  J Gastrointest Surg       Date:  2007-09-05       Impact factor: 3.452

4.  Laparoscopy-assisted proximal gastrectomy with sentinel node mapping for early gastric cancer.

Authors:  Hiroya Takeuchi; Takashi Oyama; Satoshi Kamiya; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Yoshiro Saikawa; Yuko Kitagawa
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

5.  Laparoscopic proximal gastrectomy with oblique jejunogastrostomy.

Authors:  Kimitaka Tanaka; Yuma Ebihara; Yo Kurashima; Yoshitsugu Nakanishi; Toshimichi Asano; Takehiro Noji; Soichi Murakami; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Toshiaki Shichinohe; Satoshi Hirano
Journal:  Langenbecks Arch Surg       Date:  2017-05-10       Impact factor: 3.445

6.  Laparoscopic proximal gastrectomy with jejunal interposition for gastric cancer in the proximal third of the stomach: a retrospective comparison with open surgery.

Authors:  Takahiro Kinoshita; Naoto Gotohda; Yuichiro Kato; Shinichiro Takahashi; Masaru Konishi; Taira Kinoshita
Journal:  Surg Endosc       Date:  2012-06-27       Impact factor: 4.584

7.  Long-term outcome and survival with laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer.

Authors:  Xiaohua Jiang; Naoki Hiki; Souya Nunobe; Tetsu Fukunaga; Koshi Kumagai; Kyoko Nohara; Hiroshi Katayama; Shigekazu Ohyama; Takeshi Sano; Toshiharu Yamaguchi
Journal:  Surg Endosc       Date:  2010-09-16       Impact factor: 4.584

Review 8.  Sentinel lymph node navigation surgery for gastric cancer: Does it really benefit the patient?

Authors:  Tohru Tani; Hiromichi Sonoda; Masaji Tani
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 9.  Laparoscopic proximal gastrectomy for early gastric cancer.

Authors:  Yoshitake Ueda; Hidehumi Shiroshita; Tsuyoshi Etoh; Masafumi Inomata; Norio Shiraishi
Journal:  Surg Today       Date:  2016-08-22       Impact factor: 2.549

10.  A novel method of delta-shaped intracorporeal double-tract reconstruction in totally laparoscopic proximal gastrectomy.

Authors:  Jun Hong; Li Qian; Ya-Ping Wang; Jian Wang; Lu-Chun Hua; Han-Kun Hao
Journal:  Surg Endosc       Date:  2015-09-28       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.